BioStem Technologies, Inc. (BSEM) stock
Close on Nov 20, 2026Market cap $11.34MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $11.34M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.41
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Book value per share
- $1.59
- Diluted shares
- 17M
Trading
- Previous close
- $0.71
- Open
- $0.70
- Day's range
- $0.53 – $0.71
- Volume
- 254,255
- Average volume (20 days)
- 296,005
- Beta (5 years)
- 0.55
- 52-week range
- $0.53 – $8.40
- RSI (14 days)
- 26.6
- Volatility (1 year)
- 128.3%
- Relative volume
- 1.54×
- WACC
- 7.8%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 20, 2026. The S&P 500 is measured by the SPY fund.
| Period | BSEM | S&P 500 | Difference | BSEM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -61.3% | -10.3% | −51.0 pts | ||
| 3 months | -82.7% | -9.3% | −73.4 pts | ||
| Year to date | -83.3% | +1.9% | −85.3 pts | ||
| 1 year | -83.5% | +6.9% | −90.4 pts | ||
| 3 years | -78.8% | +57.5% | −136.3 pts | -40.4% | +16.3% |
| 5 years | -25.3% | +57.3% | −82.6 pts | -5.7% | +9.5% |
| 10 years | -93.7% | +269.7% | −363.4 pts | -24.2% | +14.0% |
Two years at a glance
Fiscal years 2024 to 2025, USD
Press releases
Releases BioStem Technologies filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Results
- News
BioStem Technologies stock: common questions
What is BioStem Technologies's stock price?
BSEM closed at $0.64 on Nov 20, 2026, down 10.23% on the day. Over the past 52 weeks it traded between $0.53 and $8.40.
What is BioStem Technologies's market cap?
BioStem Technologies was worth $11.34M at the close on Nov 20, 2026: the share price times the diluted shares outstanding.
Does BioStem Technologies pay a dividend?
No. BioStem Technologies has not paid a cash dividend over the last twelve months.
How has BSEM stock performed over the past year?
Including dividends, BSEM returned -83.5% over the past year, against +6.9% for the S&P 500.
How many BSEM shares are sold short?
0M shares were sold short at the latest FINRA report, 2.83% of the float, or 1.5 days of average trading volume.
Who are BioStem Technologies's competitors?
Companies most similar to BioStem Technologies by business, industry and size include AMGN, GILD, MRNA, BIIB, BNTX.
See a number that looks wrong?